Oct 2025: International Society for Quality of Life Research (ISOQOL): Plenary Talk (TBC)

22-25 October 2025, International Society for Quality of Life Research (ISOQOL) Annual Conference, Milwaukee, Wisconsin, USA. Prof. Wac is a Plenary Speaker at the Session titled “Breaking Tradition: Disrupting Quality of Life Research with AI”.

The ISOQOL 2025 conference theme: “Artificial Intelligence & the Future of Quality-of-Life Research”
Scientists worldwide are excited and concerned about the transformation of research with the increasing use of artificial intelligence (AI). Given ISOQOL’s vision to improve the quality of life for people everywhere by creating a future in which their perspective is integral, as well as our mission to advance the science of quality of life research, this year’s conference will focus on the quality of life research in the context of artificial intelligence. Plenary sessions will focus on the theory, methods, and application of AI in quality-of-life research, along with cutting-edge research.

The plenary session: “Breaking Tradition: Disrupting Quality of Life Research with AI”
Artificial intelligence is poised to revolutionize how the patient experience is captured and interpreted in clinical research and in clinical practice. This session will examine how AI-driven approaches might redefine, or even replace, traditional methods in patient-centered outcomes research. Speakers will explore the disruptive potential of AI, focusing on emerging innovations and their implications for the field of quality of life research.

The QoL Lab’s contribution
The QoL Lab’s research focuses on digital endpoints of quality of life, particularly how AI-driven digital phenotyping and biomarkers may replace or redefine traditional patient-reported outcomes (PROs). Prof. Wac will discuss how AI-derived measures—such as passive monitoring and digital biomarkers—could shift QoL assessment away from self-reported data, potentially improving objectivity but also raising challenges around validity, interpretability, and regulatory acceptance.